2017

2017

Preparation for Phase 1 Clinical Trial of 2AP01
2017

2017

Peter Lainevool joined the Board of Directors
2016

2016

2A Pharma inlicensed the AAVLP technology from Medigene
2016

2016

2A Pharma closed its first financing round of SEK 27M, c. EURO 2.5M